NO961291D0 - Prosess II - Google Patents

Prosess II

Info

Publication number
NO961291D0
NO961291D0 NO961291A NO961291A NO961291D0 NO 961291 D0 NO961291 D0 NO 961291D0 NO 961291 A NO961291 A NO 961291A NO 961291 A NO961291 A NO 961291A NO 961291 D0 NO961291 D0 NO 961291D0
Authority
NO
Norway
Prior art keywords
agglomerates
powder
spheronizing
breath
forcing
Prior art date
Application number
NO961291A
Other languages
English (en)
Other versions
NO316747B1 (no
NO961291L (no
Inventor
Eva Trofast
Magnus Olsson
Claes Ahlneck
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9303215A external-priority patent/SE9303215D0/xx
Priority claimed from SE9304270A external-priority patent/SE9304270D0/xx
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO961291D0 publication Critical patent/NO961291D0/no
Publication of NO961291L publication Critical patent/NO961291L/no
Publication of NO316747B1 publication Critical patent/NO316747B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
    • B01J2/20—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by expressing the material, e.g. through sieves and fragmenting the extruded length
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Disintegrating Or Milling (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • External Artificial Organs (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)
NO19961291A 1993-10-01 1996-03-29 Fremgangsmate og apparat for behandling av et findelt, pulverisert legemiddel NO316747B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9303215A SE9303215D0 (sv) 1993-10-01 1993-10-01 Process II
SE9304270A SE9304270D0 (sv) 1993-12-22 1993-12-22 Process II
PCT/SE1994/000897 WO1995009616A1 (en) 1993-10-01 1994-09-29 Process ii

Publications (3)

Publication Number Publication Date
NO961291D0 true NO961291D0 (no) 1996-03-29
NO961291L NO961291L (no) 1996-03-29
NO316747B1 NO316747B1 (no) 2004-04-26

Family

ID=26661852

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19961291A NO316747B1 (no) 1993-10-01 1996-03-29 Fremgangsmate og apparat for behandling av et findelt, pulverisert legemiddel

Country Status (28)

Country Link
US (1) US6371171B1 (no)
EP (1) EP0721332B1 (no)
JP (1) JPH09504225A (no)
KR (1) KR100347497B1 (no)
CN (1) CN1119992C (no)
AT (1) ATE221371T1 (no)
AU (1) AU687896B2 (no)
BR (1) BR9407687A (no)
CA (1) CA2172055C (no)
CZ (1) CZ289394B6 (no)
DE (1) DE69431120T2 (no)
DK (1) DK0721332T3 (no)
EG (1) EG21071A (no)
ES (1) ES2178655T3 (no)
FI (1) FI117318B (no)
HU (1) HU226493B1 (no)
IL (1) IL111081A (no)
IS (1) IS1736B (no)
NO (1) NO316747B1 (no)
NZ (1) NZ274278A (no)
PL (1) PL175596B1 (no)
PT (1) PT721332E (no)
RU (1) RU2170083C2 (no)
SG (1) SG75091A1 (no)
SK (1) SK283554B6 (no)
TW (1) TW374728B (no)
UA (1) UA42736C2 (no)
WO (1) WO1995009616A1 (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4425255A1 (de) 1994-07-16 1996-01-18 Asta Medica Ag Formulierung zur inhalativen Applikation
US5983956A (en) * 1994-10-03 1999-11-16 Astra Aktiebolag Formulation for inhalation
SE9700134D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
US5980949A (en) * 1994-10-03 1999-11-09 Astra Aktiebolag Formulation for inhalation
US5826633A (en) 1996-04-26 1998-10-27 Inhale Therapeutic Systems Powder filling systems, apparatus and methods
SE9700133D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
SE9700135D0 (sv) † 1997-01-20 1997-01-20 Astra Ab New formulation
US6503537B2 (en) 1997-03-20 2003-01-07 Schering Corporation Preparation of powder agglomerates
US6495167B2 (en) * 1997-03-20 2002-12-17 Schering Corporation Preparation of powder agglomerates
ATE284677T1 (de) 1997-03-20 2005-01-15 Schering Corp Herstellung von pulveragglomeraten
US6182712B1 (en) 1997-07-21 2001-02-06 Inhale Therapeutic Systems Power filling apparatus and methods for their use
EP0938923B1 (en) * 1998-02-27 2005-03-16 Sandvik Aktiebolag Method and device for discharging free-flowing material in drop form onto a conveyor belt
US6623760B1 (en) 1999-01-28 2003-09-23 Schering Corporation Method of preparing particles for agglomeration
AU779869B2 (en) 1999-04-13 2005-02-17 Nektar Therapeutics Pulmonary administration of dry powder formulations for treating infertility
TWI310688B (en) 1999-10-29 2009-06-11 Nektar Therapeutics Dry powder compositions having improved dispersivity
WO2002096549A1 (en) * 2001-05-29 2002-12-05 Spheriform Pty Ltd Agglomeration of fine particulate material
MXPA04005865A (es) 2001-12-19 2004-09-13 Nektar Therapeutics Suministro de aminoglucosidos a los pulmones.
ES2362038T3 (es) 2003-09-02 2011-06-27 Norton Healthcare Limited Procedimiento para preparar un medicamento.
WO2005067898A2 (en) 2004-01-07 2005-07-28 Nektar Therapeutics Improved sustained release compositions for pulmonary administration of insulin
RU2389477C2 (ru) 2004-06-18 2010-05-20 Новартис Ваксинз Энд Дайагностикс Инк. Способы лечения эндобронхиальных заболеваний
CN101239330B (zh) * 2007-02-09 2010-10-27 中国石油化工股份有限公司 微球形催化剂载体的制备方法
MX2010004507A (es) * 2007-10-25 2010-07-05 Novartis Ag Acondicionamiento de polvo de paquetes de farmaco dosis unitaria.
WO2010033207A1 (en) 2008-09-19 2010-03-25 Nektar Therapeutics Polymer conjugates of therapeutic peptides
JP5668317B2 (ja) * 2009-04-24 2015-02-12 大正製薬株式会社 プソイドエフェドリン含有製剤粒子
GB201305825D0 (en) 2013-03-28 2013-05-15 Vectura Ltd New use
AU2020356243A1 (en) * 2019-09-24 2022-03-24 Chiesi Farmaceutici S.P.A. Novel carrier particles for dry powder formulations for inhalation

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1242211A (en) 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition
DE2350746C3 (de) * 1973-10-10 1978-08-31 Guenther Papenmeier Gmbh & Co Kg Maschinen- Und Apparatebau, 4930 Detmold Verfahren und Vorrichtungen zur Herstellung von Granulaten aus pulverformigem, körnigem oder teigigem Gut
GB1520247A (en) 1974-08-10 1978-08-02 Fisons Ltd Pelletised medicament formulations
GB1569611A (en) 1976-01-23 1980-06-18 Fisons Ltd Pelletised or granular medicament formulation
US4039480A (en) * 1975-03-21 1977-08-02 Reynolds Metals Company Hollow ceramic balls as automotive catalysts supports
US4161516A (en) * 1975-07-25 1979-07-17 Fisons Limited Composition for treating airway disease
US4086060A (en) * 1976-10-22 1978-04-25 Jocelyn Dickson Disposable manipulative laboratory device for transferring biological fluids
US4496376A (en) * 1978-01-26 1985-01-29 Litton Systems, Inc. Variable area molecular sieve container having a thermal control system
US4316819A (en) * 1980-08-11 1982-02-23 Uop Inc. Technique to reduce the zeolite molecular sieve solubility in an aqueous system
DE3268533D1 (en) * 1981-07-24 1986-02-27 Fisons Plc Inhalation drugs, methods for their production and pharmaceutical formulations containing them
PL135587B1 (en) * 1982-08-16 1985-11-30 Zabrzanska Fabryka Maszyn Gorniczych "Powen" Centrifugal dewatering screen
US4495308A (en) * 1983-03-04 1985-01-22 Chevron Research Company Two-region spherical catalysts
US4605173A (en) * 1984-04-04 1986-08-12 Edmonds Harvey A Size reduction machine
US4689297A (en) * 1985-03-05 1987-08-25 Miles Laboratories, Inc. Dust free particulate enzyme formulation
US4688610A (en) 1985-03-19 1987-08-25 Spiral Systems Inc. Apparatus for dispensing particulate agglomerating solids
US4655701A (en) * 1986-02-19 1987-04-07 Fuji Paudal Kabushiki Kaisha Granulating apparatus
GB8606762D0 (en) 1986-03-19 1986-04-23 Boots Co Plc Therapeutic agents
US5288500A (en) * 1987-03-13 1994-02-22 Benzon Pharma A/S Oral composition containing particles comprising an active substance
GB8711005D0 (en) 1987-05-09 1987-06-10 British Petroleum Co Plc Chemical process
DE59100388D1 (de) * 1990-01-29 1993-10-28 Ciba Geigy Verfahren und Vorrichtung zur Dosierung eines feinkörnigen Pulvers.
US5547567A (en) * 1990-10-01 1996-08-20 Cps - Chemical Products & Services A/S Apparatus for washing-down serigraphical frames and filterpart for the apparatus
GB9027018D0 (en) 1990-12-12 1991-01-30 Ici Plc Heterocyclic compounds
DE4105984A1 (de) 1991-02-26 1992-08-27 Deutsche Forsch Luft Raumfahrt Verfahren zur aufbereitung pulverfoermiger rohstoffe
US5262172A (en) * 1992-06-19 1993-11-16 Digestive Care Inc. Compositions of gastric acid-resistant microspheres containing buffered bile acids
US5399358A (en) * 1993-11-12 1995-03-21 Edward Mendell Co., Inc. Sustained release formulations for 24 hour release of metroprolol

Also Published As

Publication number Publication date
CN1132477A (zh) 1996-10-02
WO1995009616A1 (en) 1995-04-13
AU687896B2 (en) 1998-03-05
HU9600823D0 (en) 1996-05-28
HU226493B1 (en) 2009-03-02
IS1736B (is) 1999-12-30
SK39296A3 (en) 1997-06-04
KR100347497B1 (ko) 2002-12-26
JPH09504225A (ja) 1997-04-28
CZ289394B6 (cs) 2002-01-16
NZ274278A (en) 1997-07-27
SK283554B6 (sk) 2003-09-11
US6371171B1 (en) 2002-04-16
SG75091A1 (en) 2000-09-19
DE69431120T2 (de) 2002-11-28
ATE221371T1 (de) 2002-08-15
EG21071A (en) 2000-10-31
IL111081A0 (en) 1994-11-28
PL175596B1 (pl) 1999-01-29
NO316747B1 (no) 2004-04-26
DE69431120D1 (de) 2002-09-05
CZ94196A3 (en) 1996-06-12
BR9407687A (pt) 1997-02-04
FI961431A0 (fi) 1996-03-29
HUT74518A (en) 1997-01-28
EP0721332B1 (en) 2002-07-31
TW374728B (en) 1999-11-21
IL111081A (en) 1998-12-06
ES2178655T3 (es) 2003-01-01
FI117318B (fi) 2006-09-15
RU2170083C2 (ru) 2001-07-10
PL313766A1 (en) 1996-07-22
CA2172055A1 (en) 1995-04-13
DK0721332T3 (da) 2002-09-02
EP0721332A1 (en) 1996-07-17
FI961431A (fi) 1996-03-29
NO961291L (no) 1996-03-29
UA42736C2 (uk) 2001-11-15
CN1119992C (zh) 2003-09-03
IS4214A (is) 1995-04-02
CA2172055C (en) 2005-11-08
AU7826294A (en) 1995-05-01
PT721332E (pt) 2002-10-31

Similar Documents

Publication Publication Date Title
NO961291D0 (no) Prosess II
ATE386507T1 (de) Mikropartikel
US5518998C1 (en) Therapeutic preparation for inhalation
EP0757717A4 (en) PAPILLOMAVIRUS VACCINES
AU6804987A (en) Method for treating plasma and products thereof
GB9606677D0 (en) Process and device
HK1013915A1 (en) Cascade polymer complexes method of manufacture, and pharmaceutical agents containing them
DK0633792T3 (da) Separator for pulverinhalatorer
HK1044708A1 (en) Oncolytic besicular stomatitis virus
NO954996D0 (no) Anvendelse av nona- og dekapeptider for fremstilling av et legemiddel for behandling av AIDS
HRP940645A2 (en) Process for virus deactivation in the presence of polyalkylene glycol and the pharmaceutical preparation thus obtained
EP0325129A3 (en) Disubstituted pyridines
AU3598299A (en) Improved compositions for inhalation
GR3033698T3 (en) Use of a hymenoptera venom for the manufacture of a medicament for treating dna virus infections.
IE840977L (en) Pharmaceutical preparations
MX9800243A (es) Procedimiento para producir principios activos a partir de dispositivos no usados o descartados para la administracion transdermica de principios actios y/o a partir de desechos de fabricacion.
UA23309A (uk) Спосіб лікуваhhя hестабільhості плеча
EP0645399A3 (de) Ribosome inaktivierendes Protein (RIP), Verfahren zu dessen Herstellung und das Ripenthaltende pharmazeutische Zubereitung.
Potetnya et al. The effect of hyperthermia on the chromosome aberration output in the irradiation of human lymphocytes at the G sub (1) stage with super (252) Cf and super (60) Co sources of various dose rates.
UA9028A (uk) Спосіб відновлення працездатності хворих бронхіальною астмою

Legal Events

Date Code Title Description
MK1K Patent expired